Progenics Pharmaceuticals, Inc.

Form 483FOIA Uncovered

Somerset, New Jersey, United StatesFEI 3013995400Issued March 20, 2020

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3013995400.

Observations8

Issue DateMarch 20, 2020

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Progenics Pharmaceuticals, Inc.
Location: Somerset, New Jersey, United States
FEI Number: 3013995400
Product Type: Drugs
Issue Date: March 20, 2020
Country: United States

Inspection History, 2020 to 2023

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Progenics Pharmaceuticals, Inc. FDA Form 483, Somerset, New Jersey, March 20, 2020